Electromed (ELMD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $28.03, +2.00% vs the prior close of $27.48.
- Volume 56.90K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ELMD rises 2.0% to $28.03. Closed at $28.03, +2.00% vs the prior close of $27.48. Day range $27.62–$28.30, opened at $27.62.
ELMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ELMD rises 2.0% to $28.03
- Closed at $28.03, +2.00% vs the prior close of $27.48. Day range $27.62–$28.30, opened at $27.62.
- Volume was 56.90K shares, 0.6x its 50-day average of 95.48K — lighter than usual.
- Price is -11.2% vs its 50-day average ($31.57) and -10.6% vs its 200-day average ($31.36).
- 52-week range $23.01–$47.40; today's close sits at 21% of that range, 40.9% below the 52-week high.
Oct 14, 2026 — ELMD dips 0.7% to $27.48
- Closed at $27.48, -0.72% vs the prior close of $27.68. Day range $27.15–$27.62, opened at $27.62.
- Volume was 64.40K shares, 0.7x its 50-day average of 95.49K.
- Price is -13.7% vs its 50-day average ($31.85) and -12.4% vs its 200-day average ($31.36).
- 52-week range $23.01–$47.40; today's close sits at 18% of that range, 42.0% below the 52-week high.
Oct 13, 2026 — ELMD dips 1.5% to $27.68
- Closed at $27.68, -1.53% vs the prior close of $28.11. Day range $27.40–$28.32, opened at $28.25.
- Volume was 60.80K shares, 0.6x its 50-day average of 95.80K.
- Price is -13.9% vs its 50-day average ($32.14) and -11.8% vs its 200-day average ($31.37).
- 52-week range $23.01–$47.40; today's close sits at 19% of that range, 41.6% below the 52-week high.
Oct 12, 2026 — ELMD rises 1.5% to $28.11
- Closed at $28.11, +1.52% vs the prior close of $27.69. Day range $27.61–$28.31, opened at $27.68.
- Volume was 94.00K shares, 1.0x its 50-day average of 94.99K.
- Price is -13.3% vs its 50-day average ($32.42) and -10.4% vs its 200-day average ($31.37).
- 52-week range $23.01–$47.40; today's close sits at 21% of that range, 40.7% below the 52-week high.
Oct 9, 2026 — ELMD dips 0.4% to $27.69, 4 down days in a row
- Closed at $27.69, -0.40% vs the prior close of $27.80. Day range $27.52–$28.21, opened at $27.82.
- Volume was 51.00K shares, 0.5x its 50-day average of 95.04K — lighter than usual.
- Price is -15.2% vs its 50-day average ($32.67) and -11.7% vs its 200-day average ($31.37).
- 52-week range $23.01–$47.40; today's close sits at 19% of that range, 41.6% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — ELMD dips 1.4% to $27.80, 3 down days in a row
- Closed at $27.80, -1.42% vs the prior close of $28.20. Day range $27.38–$28.07, opened at $27.97.
- Volume was 107.00K shares, 1.1x its 50-day average of 94.05K.
- Price is -15.6% vs its 50-day average ($32.92) and -11.4% vs its 200-day average ($31.37).
- 52-week range $23.01–$47.40; today's close sits at 20% of that range, 41.4% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ELMD ends flat (-0.2%) to $28.20
- Closed at $28.20, -0.25% vs the prior close of $28.27. Day range $27.70–$28.37, opened at $28.03.
- Volume was 74.90K shares, 0.8x its 50-day average of 94.38K.
- Price is -15.0% vs its 50-day average ($33.17) and -10.1% vs its 200-day average ($31.38).
- 52-week range $23.01–$47.40; today's close sits at 21% of that range, 40.5% below the 52-week high.
Oct 6, 2026 — ELMD ends flat (-0.2%) to $28.27
- Closed at $28.27, -0.18% vs the prior close of $28.32. Day range $27.67–$28.43, opened at $28.40.
- Volume was 60.40K shares, 0.6x its 50-day average of 94.47K.
- Price is -15.3% vs its 50-day average ($33.39) and -9.9% vs its 200-day average ($31.38).
- 52-week range $23.01–$47.40; today's close sits at 22% of that range, 40.4% below the 52-week high.
Oct 5, 2026 — ELMD rises 0.8% to $28.32
- Closed at $28.32, +0.78% vs the prior close of $28.10. Day range $27.56–$28.48, opened at $28.09.
- Volume was 69.50K shares, 0.7x its 50-day average of 94.43K.
- Price is -15.8% vs its 50-day average ($33.63) and -9.8% vs its 200-day average ($31.39).
- 52-week range $23.01–$47.40; today's close sits at 22% of that range, 40.3% below the 52-week high.
Oct 2, 2026 — ELMD dips 1.4% to $28.10
- Closed at $28.10, -1.40% vs the prior close of $28.50. Day range $27.67–$28.75, opened at $28.53.
- Volume was 84.80K shares, 0.9x its 50-day average of 94.25K.
- Price is -16.9% vs its 50-day average ($33.83) and -10.5% vs its 200-day average ($31.40).
- 52-week range $23.01–$47.40; today's close sits at 21% of that range, 40.7% below the 52-week high.
ELMD latest news & SEC filings
Every SEC filing by or about ELMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 29, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 29, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 25, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended Jun 30, 2026:
- Revenue: $73.78M (prior year $64.00M) (+15.3% vs Jun 30, 2025)
- Net income: $11.30M (prior year $7.54M) (+49.9% vs Jun 30, 2025)
- Diluted EPS: $1.30 (prior year $0.85) (+52.9% vs Jun 30, 2025)
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade ELMD
- Last results release: Aug 25, 2026 (8-K Item 2.02). Previous ones: May 12, 2026, Feb 10, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 24, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.94% (largest 2.1%). That is a relatively calm stock.
- Liquidity: about 88.22K shares (≈$2.47M) trade per day on average.
- 52-week position: $28.03 vs a range of $23.01–$47.40 (21% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 9 sales; latest: James L. Cunniff sold 7,003 shares on Jun 8, 2026.
- Latest filings: 8-K Aug 25, 2026; 10-K Aug 25, 2026; 10-Q May 12, 2026.
- Share count: 8.37M shares outstanding (Aug 19, 2026), +0.2% vs a year earlier.
- Listing: NYSE · industry: Electromedical & Electrotherapeutic Apparatus.
ELMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 27.62 | 28.30 | 27.62 | 28.03 | 56.90K |
| Oct 14, 2026 | 27.62 | 27.62 | 27.15 | 27.48 | 64.40K |
| Oct 13, 2026 | 28.25 | 28.32 | 27.40 | 27.68 | 60.80K |
| Oct 12, 2026 | 27.68 | 28.31 | 27.61 | 28.11 | 94.00K |
| Oct 9, 2026 | 27.82 | 28.21 | 27.52 | 27.69 | 51.00K |
| Oct 8, 2026 | 27.97 | 28.07 | 27.38 | 27.80 | 107.00K |
| Oct 7, 2026 | 28.03 | 28.37 | 27.70 | 28.20 | 74.90K |
| Oct 6, 2026 | 28.40 | 28.43 | 27.67 | 28.27 | 60.40K |
| Oct 5, 2026 | 28.09 | 28.48 | 27.56 | 28.32 | 69.50K |
| Oct 2, 2026 | 28.53 | 28.75 | 27.67 | 28.10 | 84.80K |
| Oct 1, 2026 | 28.11 | 28.95 | 27.87 | 28.50 | 86.50K |
| Sep 30, 2026 | 28.29 | 28.46 | 27.60 | 28.23 | 145.10K |
| Sep 29, 2026 | 28.07 | 28.33 | 27.27 | 28.33 | 95.20K |
| Sep 28, 2026 | 27.76 | 28.27 | 27.72 | 28.17 | 87.80K |
| Sep 25, 2026 | 27.91 | 27.97 | 27.35 | 27.88 | 92.80K |
| Sep 24, 2026 | 27.50 | 27.99 | 27.25 | 27.86 | 64.70K |
| Sep 23, 2026 | 27.41 | 27.76 | 27.12 | 27.57 | 71.80K |
| Sep 22, 2026 | 27.47 | 28.35 | 27.27 | 27.57 | 148.30K |
| Sep 21, 2026 | 26.05 | 27.50 | 26.05 | 27.00 | 107.10K |
| Sep 18, 2026 | 26.35 | 26.81 | 26.04 | 26.53 | 141.40K |
About Electromed
Electromed (ELMD) is listed on the NYSE and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in NEW PRAGUE, MN. State of incorporation: MN. Fiscal year ends June 30. SEC CIK 1488917.
ELMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| James L. Cunniff | CEO and President | Sep 3, 2026 |
| Stan K. Erickson | Director | Dec 3, 2025 |
| Gregory Fluet | Director | Dec 3, 2025 |
| Joseph L. Galatowitsch | Director | Dec 3, 2025 |
| Kathleen Skarvan | Director | May 19, 2026 |
| Andrew Summers | Director | Dec 3, 2025 |
| Kathleen A Tune | Director | Dec 3, 2025 |
| Andrea M. Walsh | Director | Dec 3, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| James L. Cunniff | CEO and President | Sep 3, 2026 |
| Bradley M. Nagel | Chief Financial Officer | Sep 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 8, 2026 | James L. Cunniff | Sale | 7,003 | $36.25 |
| Jun 8, 2026 | James L. Cunniff | Sale | 1,671 | $36.80 |
| Jun 8, 2026 | James L. Cunniff | Sale | 1,026 | $37.77 |
| Jun 4, 2026 | Bradley M. Nagel | Sale | 181 | $37.11 |
| Jun 4, 2026 | Bradley M. Nagel | Sale | 11,620 | $36.34 |
| May 15, 2026 | Kathleen Skarvan | Sale | 8,150 | $34.36 |
| May 15, 2026 | Kathleen Skarvan | Sale | 3,562 | $37.33 |
| May 15, 2026 | Kathleen Skarvan | Sale | 19,032 | $35.24 |
| May 15, 2026 | Kathleen Skarvan | Sale | 9,256 | $36.26 |
ELMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | $73.78M | $11.30M | 1.30 | $9.66M |
| Jun 30, 2025 | $64.00M | $7.54M | 0.85 | $11.39M |
| Jun 30, 2024 | $54.72M | $5.15M | 0.58 | $9.07M |
| Jun 30, 2023 | $48.07M | $3.17M | 0.36 | $1.31M |
| Jun 30, 2022 | $41.66M | $2.31M | 0.26 | $-686.00K |
Latest balance sheet: total assets $66.27M, total liabilities $12.29M, cash $20.45M (as of Jun 30, 2026).
ELMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 25, 2026 | 8-K Item 2.02 (results) | $39.34 |
| May 12, 2026 | 8-K Item 2.02 (results) | $27.20 |
| Feb 10, 2026 | 8-K Item 2.02 (results) | $28.06 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $25.38 |
| Aug 26, 2025 | 8-K Item 2.02 (results) | $20.66 |
| May 13, 2025 | 8-K Item 2.02 (results) | $22.83 |
| Feb 11, 2025 | 8-K Item 2.02 (results) | $29.20 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $26.44 |
| Aug 27, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 13, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)TransMedics (TMDX)Integer (ITGR)LivaNova (LIVN)Axogen (AXGN)Ceribell (CBLL)Conmed (CNMD)InMode (INMD)Neuraxis (NRXS)CapsoVision (CV)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ELMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.